Stockreport

FDA clears Entellus Med's ENT dilation device for persistent ETD [Seeking Alpha]

ENTELLUS MEDICAL  (ENTL) 
Last entellus medical earnings: 11/1 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.entellusmedical.com
PDF The FDA grants 510(k) clearance for the use of Entellus Medical's (NASDAQ: ENTL ) XprESS ENT Dilation System in patients with persistent Eustachian tube dysf [Read more]